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Background 
In 1980, Saugstad and Aasen introduced the concept of hypoxia-reoxygenation injury 
through oxygen free radicals and suggested that care should be taken when using pure 
oxygen during resuscitation (1). Since then, researchers at the Department of Pediatric 
Research, among others, have worked on the intriguing questions concerning oxygen 
concentration during neonatal resuscitation. Numerous publications and theses have been 
presented, all adding a little more knowledge to a complex subject. Although oxygen is 
widely used, more than 200 years after its discovery we still do not know in detail: 
1) The optimal oxygen concentration and saturation during resuscitation of the 
newly born;
2)  The short- and long-term effects on morbidity and mortality and on growth 
and development of using oxygen in the newborn period. 
With this thesis, I hope to participate in the ongoing debate on whether to use ambient air, 
pure oxygen or an intermediate dissolution in neonatal resuscitation. 
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Introduction 
Birth asphyxia 
Epidemiology
Approximately 4 million infants out of the 130 million worldwide annual births suffer 
from birth asphyxia. Of these, approximately 25% die and 25% develop some kind of 
sequelae (2). Birth asphyxia ranks first among the perinatal insults that cause 
neurodevelopmental handicap in the newborn, particularly in the full-term baby (3). 
Definition
Asphyxia is defined as a condition of impaired gas exchange that leads to three 
biochemical effects: hypoxemia, hypercapnia and metabolic acidosis (4). Because of the 
uterine contraction during the normal birth process, all foetuses experience some 
impairment of gas exchange. The term “asphyxia” should not be used unless the neonate 
meets all of the following conditions (5): 
x Evidence of metabolic acidosis in foetal umbilical cord arterial blood obtained at 
delivery (pH < 7 and base deficit  12 mmol/L). 
x Apgar scores of 0 - 3 for five minutes or more. 
12
x Evidence of neurological sequelae (e.g. seizures, coma, hypotonia) and one or 
more of the following organ system injuries: cardiovascular, gastrointestinal, 
haematological, pulmonary or hepatic injury or renal system dysfunction. 
To evaluate neurological sequelae, the combination of magnetic resonance imaging 
(MRI) and proton magnetic resonance spectroscopy (HMRS) also makes it possible to 
evaluate severity and to help predict the outcome of hypoxic-ischemic encephalopathy 
(HIE) (6).
A diagnosis of the asphyxiating event is associated with the interruption of the oxygen 
supply or blood flow to the foetus, which can be secondary to problems in the mother 
(e.g. hypotension, pre-eclampsia, uterine tetany, uterine rupture), the placenta or the 
umbilical cord (e.g. abruption, infection or inflammation, umbilical cord compression or 
occlusion), or in the foetus or infant (e.g. central nervous system depression, anomalies, 
infection) (7).  
Hypoxic-ischemic encephalopathy
Birth asphyxia is probably best diagnosed and assessed by what it leads to. The foetus 
that experiences a significant asphyxial episode is at risk of developing HIE or other 
organ sequelae. HIE is caused in the full-term and post-term newborn, while in the pre-
term newborn unspecific changes occur due to the immaturity of the central nervous 
system (8). It should be diagnosed only when an infant has clinical findings of an 
encephalopathy, such as neurological depression or seizures, and has experienced a 
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severe asphyxiating event (9). The severity of HIE is probably the strongest clinical 
predictor of outcome in asphyxiated newborn infants. According to the modification of 
Sarnat and Sarnat (10, 11), HIE is classified in three clinical stages. Mild HIE (grade I) 
includes irritability, poor sucking and mild hypotonia, and always has a positive outcome. 
Moderate HIE (grade II) includes lethargy, marked abnormalities of muscle tone, seizures 
and the need for tube feeding, and leads to severe handicap in approximately 20% of the 
cases. Severe HIE (grade III) includes coma, prolonged seizures, severe hypotension and 
respiratory failure, and in most cases results in severe handicap or death (12).
Mechanisms
Hermansen described the acidosis paradox, i.e. a beneficial effect of a mild to moderate 
acidosis (13). He described three mechanisms that could theoretically limit cerebral 
damage. Hypercarbia may result in cerebral vasodilatation and increased cerebral flow. 
Acidosis decreases cerebral metabolism, lowers the cerebral oxidative needs and 
promotes the unloading of oxygen from the foetal haemoglobin by shifting the oxygen 
dissociative curve. These protective mechanisms can be lost with severe acidosis, which 
further decreases cardiac output and secondary cerebral ischemia (14). When the pH 
decreases below 7, the risk of developing long-term cerebral damage increases (15). 
When asphyxia occurs, the organism sets off the necessary mechanisms to preserve vital 
organs (brain, heart, and adrenal glands), while other organs such as the kidney, lungs, 
gastrointestinal tract and skin are affected to a greater or lesser degree depending on the 
duration of the episode (16). When compensatory mechanisms fail, the brain is affected 
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by HIE. The cardiovascular system is affected by myocardial ischemia or cardiac 
stunning, poor contractility due to acidosis, tricuspid insufficiency (often from pulmonary 
hypertension) and hypotension (17).
Brain injury secondary to hypoxic-ischemic disease is the predominant form encountered 
in the term infant (18). Cell damage may occur both during the ischemic phase and upon 
reperfusion, probably by different mechanisms (19). The normal function of the brain 
inevitably depends on an adequate supply of oxygen and glucose. Acute reduction in 
cerebral oxygen delivery leads to the breakdown of neuronal energy metabolism within 
few minutes (20). When the cerebral blood flow is compromised, brain cells are deprived 
of oxygen and glucose, resulting in a decrease in high energy phosphate (ATP) levels. 
Ionic gradients across the cell membrane cannot be maintained, partly due to loss of 
Na /K -ATPase activity. Influx of Na  and Ca  into the cell is accompanied by water, 
resulting in cytotoxic oedema. These changes may become irreversible and lead to cell 
necrosis and brain infarction as a result of ischemia alone. Reperfusion may temporarily 
correct the energy failure, but it may trigger a chain of events leading to delayed neuronal 
death or secondary damage due to brain swelling (19). 
+ + + 2+
The acute lack of cellular energy 
during ischemia induces almost complete inhibition of cerebral protein biosynthesis.
A second wave of neuronal cell damage occurs during the reperfusion phase induced by 
the post ischemic release of oxygen radicals, the synthesis of nitric oxide (NO), 
inflammatory reactions and an imbalance between the excitatory and inhibitory 
neurotransmitter systems (21). Knowledge about these pathophysiological mechanisms 
has enabled scientists to develop new therapeutic strategies that have been shown to be 
neuroprotective in animal experiments. Promising therapeutic effects are seen by the post 
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ischemic induction of mild cerebral hypothermia (22, 23), the application of the calcium-
antagonist flunarizine, and the administration of magnesium (24-26). 
Chronic lung disease  
Definition and epidemiology 
Bronchopulmonary dysplasia (BPD), now more commonly referred to as chronic lung 
disease of infancy (CLD), was first described by Northway and colleagues in 1967. CLD 
is defined as chronic oxygen dependency in newborns at 36 weeks post-menstrual age 
(27). The incidence of CLD in infants with a birth weight between 500 and 1500 g ranges 
between 3% and 43% (28). CLD affects almost half of all ventilated infants below 32 
weeks’ gestation, and contributes significantly to the long-term morbidity of preterm 
infants (29). Despite improvements in neonatal intensive care over the last ten years, 
including the widespread use of exogenous surfactant and antenatal steroids, there has 
been little alteration in the incidence of this disease (30). This is believed in part to be due 
to the improving survival of extremely preterm infants who now proceed to develop 
CLD. It has also been noted that the nature of CLD has altered. Previously, CLD affected 
larger infants with severe Respiratory Distress Syndrome (RDS) who were exposed to 
high ventilatory pressures and oxygen concentrations, and were characterised by an 
inflammatory response to this treatment. Now CLD affects extremely preterm infants 
who may not have significant RDS at birth but have immature pulmonary development. 
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Exposure to the extra-uterine environment and to treatment modalities result in abnormal 
lung development (31). 
Mechanisms
The development of CLD has been associated with the use of hyperoxic treatment during 
ventilation. Inflammation has been shown to contribute to the development of this disease 
both on histological examination of diseased lungs and by the use of bronchoalveolar 
lavage (32). Hyperoxia is believed to contribute to this inflammatory process by causing 
direct injury to epithelial and endothelial cells. The formation of reactive oxygen species 
is thought to result in a cytokine production and vice versa (33). They act within a 
complex network and orchestrate an inflammatory response. The mechanism, by which 
this disease process occurs, has become progressively elucidated with time by the use of 
in vitro and in vivo investigations. Preterm infants are particularly vulnerable to oxygen 
toxicity as a consequence of an immature antioxidant system. Complex cytokine 
networks play a crucial role in the pathophysiology of CLD and provide a target for 
therapeutic modulation. Pulmonary metalloproteinases may also be activated in the early 
stages of CLD (34, 35). 
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Treatments
A number of treatments have been investigated which down-regulate the immune 
response in a non-specific manner e.g. corticosteroids and non-steroidal anti-
inflammatory drugs. However, these treatments have many undesired side-effects that 
limit their usefulness (30). 
Cardiovascular dysfunction in birth asphyxia 
Cardiovascular dysfunction related to birth asphyxia was first described in the 1970s 
(36). The incidence is not well known, but cardiac abnormalities should be suspected in 
seriously asphyxiated infants. In most cases these are reversible within a few days 
without any treatment. Severe hypoxic myocardial dysfunction most often occurs in 
seriously asphyxiated children, usually in combination with other serious organ failures 
that mask the cardiac problem. When an asphyxic event occurs, the organism sets off a 
series of mechanisms to ensure that vital organs such as the brain and heart continue 
working normally. When the event prevails in spite of compensatory mechanisms, it may 
affect the vital organs.
Myocardial dysfunction, hypotension and increased pulmonary vascular resistance are 
well-known consequences of hypoxic-ischemic insults in neonates and are related to low 
alveolar oxygen tension and increased pulmonary vascular resistance (37). The 
abnormalities can be classified as transient tricuspid regurgitation (TR), transient 
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myocardial ischemia (TMI), transient mitral regurgitation (MR), and persistent 
pulmonary hypertension of the newborn (PPHN) (17).
1) TR has been described as the most common cause of cardiac murmur in the newborn 
during the first days of life. It is most often associated with PPHN (persistent pulmonary 
hypertension of the newborn), both probably being due to asphyxial damage. It tends to 
disappear after a few days and seldom causes long-term problems. Isolated TR needs no 
therapy unless associated with TMI or PPHN. 
2) In the most severe cases TMI may cause an acute myocardial infarction (8). TMI 
should be suspected in an asphyxiated newborn with respiratory distress and poor pulses - 
especially if a murmur is detected. Cardiac Troponin I have been shown to be a sensitive 
andspecific marker of myocardial damage in both the adult andpediatric population (38, 
39)
3) MR is far less common than TR and is often part of transient myocardial ischemia. 
This condition is recognised as a pan systolic murmur of the apex, and may reduce the 
left ventricular function. MR requires therapy more often than TR as it is commonly 
associated with TMI and left ventricular dysfunction. 
4) Persistent pulmonary hypertension of the newborn (PPHN) is a condition in which the 
hemodynamics of fetal life are maintained after birth. The pulmonary vascular bed 
remains constricted and there is right to left shunting across the ductus arteriosus and 
foramen ovale. Perinatal hypoxia is one cause of the development of PPNH. 
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Apgar score 
The Apgar score - a widely used method for the immediate evaluation of the newborn 
infant’s condition - was first developed in 1952 by Dr. Virginia Apgar, an obstetric 
anaesthesiologist (40). Using signs traditionally observed by anaesthesiologists, her goal 
was to develop a scoring system that could assess a neonate’s transition after birth. It was 
developed as an objective tool which measures five signs of physiologic adaptation. The 
score is based on the sum of the values assigned to the infant at one and five minutes of 
life, with a score of seven or more indicating that the baby is in good to excellent 
condition (9). The initial intent of the Apgar score was to predict survival and not 
perinatal asphyxia. Although the Apgar score can to some extent predict mortality, it is 
not a tool to be used alone in determining the neurological outcome of infants who 
survive. Low Apgar scores estimated during the first few minutes of life are not specific 
to any particular condition and are poor predictors of brain injury (41-43). The score does 
not take into account preterm infants or intubated infants who often gain lower scores 
based on these situations. It has also been suggested that it is antiquated due to the 
modern application of resuscitation and neonatal care (9).
Normal blood oxygen saturation during the first few minutes of life is below 85%. A one 
minute Apgar score of nine or ten is probably not ideal and should not be a goal. Indeed, 
the Apgar score might have contributed to the subsequent excessive use of oxygen in 
newborn infants (44).
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Oxygen in neonatal medicine           
Karl Scheele and Joseph Priestly discovered oxygen independently in 1772 and 1774. 
Priestly realised that this gas was not only life-giving but might be poisonous as well 
“The new air might not be proper for use in the healthy states of the body…the air which 
nature has provided us may be as good as we deserve”. Shortly after its discovery, 
oxygen was used for medical purposes. In 1780, Chaussier in France administered 
oxygen in order to establish normal breathing in newborn infants and in the years to come 
oxygen as a therapeutic agent was tested out in a number of conditions. 
The gas was administered by various techniques (subcutaneous injections, iv, 
intragastrically) in order to resuscitate premature infants and to manage attacks of 
apnoea. In 1893 Thomas Morgan Rotch proposed that oxygen should be applied two or 
three times each day into the incubator of newborn infants as a “stimulant”. In 1928 
Flagg described a procedure for intubation and intermittent positive pressure insufflations 
using a mixture of oxygen and carbon dioxide for resuscitating asphyxiated newborns 
(45). Routine oxygen therapy for newborn infants was introduced in the United States in 
the 1930s in order to improve the respiratory pattern and to reduce a supposed risk of 
brain damage caused by unrecognised lack of oxygen (46). After 1945 incubators were 
used to maintain a high oxygen concentration. From a biochemical point of view it 
seemed logical and intuitive to reverse the anaerobic state as quickly as possible with 
100% oxygen since 18-19 times more ATP is produced from glucose during aerobic 
metabolism than during anaerobic metabolism. However, following the discovery of the 
link between retinopathy of prematurity, chronic lung disease (CLD) and the liberal use 
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of supplemental oxygen therapy, controversy has surrounded the use of oxygen in 
neonatology (47, 48).
Is it harmful to resuscitate neonates with pure oxygen? 
In the past 12 years, neonatal research has concluded that if assisted ventilation is 
required, room air is as efficient as 100% oxygen for newborn resuscitation (49, 50). 
Clinical and experimental studies have also concluded that resuscitation with oxygen 
might have detrimental effects (51, 52). A meta-analysis published in the Lancet (53) 
even suggested that mortality is lower in newborn infants resuscitated with room air 
compared with those resuscitated with 100% oxygen, with one death being prevented for 
every 20 babies resuscitated with air versus 100% oxygen. The recent meta-analyses (53, 
54) investigating data over 12 years of translational research strongly suggests that our 
practice of resuscitating term infants who need positive pressure ventilation in 100% 
oxygen should in most cases be avoided. Neonatal medicine and newborn resuscitation 
guidelines and practice need to be revised globally.
Neonatal resuscitation
Rapid and complex physiological changes occur during birth. The neonate has to make 
the transition from a fluid-filled environment in which the placenta serves as the gas-
exchange organ for the foetus to an air-filled environment in which the neonate’s own 
cardiopulmonary system has to function independently within minutes of birth for 
survival. Amazingly at least 90% of neonates successfully make this transition without 
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the need of help. The remaining 10% of newborns require some assistance to begin 
breathing at birth, and about 1% may require intensive resuscitation efforts (55, 56). Thus 
resuscitation of the newly born infant is one of the most widely practiced medical 
procedures, and oxygen is the most commonly used remedy in neonatal units as an 
integral part of respiratory support (57). Of course, the aim of resuscitation is to prevent 
neonatal death and adverse long-term sequelae. 
The optimal concentration of oxygen for neonatal resuscitation is uncertain. Guidelines 
from the American Heart Association and the American Academy of Pediatrics (2000) 
recommend that pure oxygen should be used during initial newborn resuscitation 
whenever positive pressure ventilation is required (58). This practice has been challenged 
by other experts in the field, on the basis that insufficient scientific evidence exists to 
support it. The neonatal resuscitation program currently recommends discontinued 
resuscitation if heart rate is absent after 15 minutes of appropriate resuscitation. This is 
based on data that newborns who are asystolic at ten minutes of life usually die, and if 
they survive they have severe disabilities (59-62). New guidelines for the resuscitation of 
depressed newborn infants, which were discussed at the conference “2005 International 
Consensus on cardiac pulmonary resuscitation (CPR) and emergency cardiovascular care 
(ECC) Science with Treatment Recommendations Conference” in Dallas, January 2005, 
will be published later this year. Defining the optimal oxygen concentration and 
technique for neonatal resuscitation is an extremely important challenge and has the 
potential to improve neonatal outcome globally.
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Perinatal hypoxic-ischemic tissue damage 
Oxidative stress 
Birth is accompanied by an increasing oxidative stress as birth itself is a hyperoxic 
challenge. The foetus is moved from an intrauterine hypoxic environment with a pO2 of
2.6-3.3 mmHg to an extrauterine environment with a pO2 of 13.3 mmHg. The link 
between oxygen and the generation of oxygen free radicals (OFRs) was described 50 
years ago (63).
OFRs are highly cytotoxic molecules generated during the restoration of oxygenated 
blood flow following ischemia or hypoxia (64). They are cytotoxic because they have the 
ability to interact with and alter the principal components of cells including proteins, 
lipids, carbohydrates and DNA (65-68). They also play important roles in normal 
biological processes, apoptosis and necrosis (69). 
In 1988, Saugstad introduced the term “oxygen radical disease in neonatology”, 
suggesting an important role of OFR in the generation of different neonatal morbidities 
(70). Animal and human studies have shown an increasing OFR production with higher 
levels of inspired oxygen and degree of prematurity (71, 72).  Perinatal asphyxia is a 
hypoxic-ischemic event, and with subsequent resuscitation infants are at risk of OFR-
related injury to the vital organs (73).  They are implicated in the pathogenesis of many 
neonatal diseases such as perinatal asphyxia, chronic lung disease (CLD), retinopathy of 
prematurity (ROP), necrotizing enterocolitis, interventricular hemorrhage, periventricular 
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leucomalacia, pulmonary hypertension, persistence of ductus arteriosus and myocardial 
dysfunction (64, 74-79).
The lungs are directly exposed to the highest partial pressure of inspired O2 and, together 
with its large surface area and blood supply, they are susceptible to injury mediated by 
OFR. Pulmonary damage as a result of oxygen exposure is an important clinical 
complication in patients treated with high levels of oxygen (67). The initial phase of 
pulmonary oxygen toxicity is characterised by damage to airway and alveolar epithelium 
and capillary endothelium. This leads to interstitial and alveolar oedema followed by 
marked neutrophil infiltration into the tissue. The second phase of oxygen toxicity is 
characterised by proliferation of alveolar type II cells and after prolonged exposure by 
interstitial fibrosis (80). This results in permanently impaired gas exchange. Oxygen-
induced lung injury is manifested as CLD in premature infants. The second category of 
toxic effects induced by oxygen is indirect. The neonatal brain, in particular the preterm 
brain, is vulnerable to oxidative damage due to its high concentration of unsaturated fatty 
acids, its low concentration of antioxidants and the availability of redox-active iron (81). 
However, as OFRs in abundance can be harmful, they also play important physical roles, 
which include signal transduction and the regulation of cellular growth and 
differentiation (82) and vasoactive control (83), and they are involved in the defence 
against infection and in mediating immune responses (84-86). 
Matrix metalloproteinases
It has previously been reported that oxygen free radicals (OFRs) induce gene expression 
of several matrix metalloproteinases (MMPs) (87). Several studies have documented 
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early up-regulation of MMPs in acute disease processes, such as ischemia-reperfusion 
and hyperoxia in the brain, lungs (35) and heart (88-94). MMPs are a group of zink-
dependent endopeptidases involved in the process of tissue remodelling through the 
degradation of the extracellular matrix (ECM) (95). Tissue remodelling occurs in various 
physiologic conditions such as embryogenesis and wound healing, as well as in 
pathologic conditions, including inflammatory diseases, tumor cell invasion and 
angiogenesis (96). The activity of MMPs is regulated by several types of inhibitors, the 
most important of which are the tissue inhibitors of metalloproteinases (TIMPs) (97). The 
role of oxidative stress and its toxic effects on lipids, as well as on the disruption of extra 
cellular matrix through the up- regulation of MMPs is well established (98-100).
Uncontrolled expression of MMPs can result in tissue injury and inflammation (95, 101).
In myocardial tissue, MMP-2, activated by oxidants, can cause a detrimental effect on the 
myocardial contractile function after reperfusion caused by its action on the troponin and 
contractile mechanism (92, 102-104).  
Glycerol
Degradation of membrane phospholipids is a well-known phenomenon that is thought to 
underlie the disturbance of vital cellular membrane functions in acute brain injuries. 
Glycerol is an integral part of the hydrophilic portion of the bilayer of glycerophosphate 
and fatty acids that constitute most cell membranes. Hypoxia-ischemia (HI) increases 
intracellular calcium, which will activate phospholipases and thereby degrade the bilayer 
into fatty acids, phosphate and glycerol. Interstitial glycerol is a sensitive and reliable 
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marker of cell damage in experimental cerebral ischemia (105-107). In the hypoxic term 
piglet model, the corpus striatum becomes selectively vulnerable (108). 
Interleukin-8
In pulmonary tissue, IL-8 is synthetised by circulating monocytes, alveolar macrophages, 
T-lymphocytes, type II pneumocytes, epithelial and endothelial cells (32). Hyperoxia is 
known to stimulate the alveolar macrophages to release chemokines such as IL-8 into the 
alveolar space (90) thereby up-regulating MMP-2 and MMP-9 production (109). 
Overproduction of pro-inflammatory cytokines has been suggested to be a major factor 
associated with pulmonary damage. In vivo, IL-8 is abundantly expressed in the lungs of 
animal models during oxygen injury (110) and in human premature infants developing 
CLD (111, 112). Earlier studies have noted a significant rise in IL-8 levels in broncho 
alveolar lavage (BAL) fluid (113, 114). Munshi (115) noted a significant rise of IL-8 in 
tracheal aspirates one to three days postnatally in babies with RDS progressing to CLD. 
In clinical studies, increased levels of pro-inflammatory cytokines (i.e. IL-8) in BAL 
fluid, correlated with the degree of pulmonary dysfunction and predicted the development 
of chronic lung disease in premature infants (116). 
Magnetic resonance imaging
Magnetic resonance imaging (MRI) is an attractive diagnostic modality in the developing 
brain because of the high contrast resolution of this technique combined with its relative 
non-invasiveness (117). MR perfusion and diffusion weighted imaging (PWI and DWI) 
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have proved to be sensitive tools for the early detection of brain injury (118-121). The 
almost instant reduction in microscopic tissue water diffusion following cerebral 
ischemia, demonstrated with DWI in cats as early as 1990, is well documented (122). The 
mechanism behind the diffusion reduction during ischemia is still not fully understood, 
but it is most commonly thought to be caused by cytotoxic oedema which results from 
the breakdown of the cellular membrane Na+/K+-ATPase pump system (123). DWI has 
lately been shown to be a very sensitive method for diagnosing severe neonatal HIE (124, 
125).  The use of cerebral PWI is a relatively new diagnostic method, but is already well 
established in the diagnosis of brain ischemia. In particular, the combination of PWI and 
DWI has been shown to be a very sensitive and non-invasive method for identifying the 
ischemic penumbra as the area of mismatch between perfusion and diffusion changes 
(126). PWI (in terms of relative perfusion maps, rCBF) directly reflects the area of 
perfusion reduction, and therefore the area at risk of infarction, whereas the region with 
decreased water diffusion is thought to reflect the area that is irreversibly damaged. The 
availability of a well-controlled piglet model is of great importance for many types of 
studies aimed at investigating neonatal injury due to HI. Such a model requires a 
sensitive method in order to assess the degree of functional changes caused by the 
induction of HI. Another important aspect is to have a sensitive imaging method to 
validate that total carotid occlusion has indeed been achieved. By contrast, this could be 
performed enhanced MR angiography (MRA), possibly combined with immediate 
perfusion imaging.  
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Aims of the study 
1. To explore whether resuscitation with 100% oxygen compared with ambient air 
increases acute cerebral, pulmonary and myocardial damage. 
2. To explore whether alterations in the PaCO2 - level during resuscitation influences the
cerebral, pulmonary and myocardial tissue. 
3. To assess if morphological and haemodynamic magnetic resonance imaging in the 
brain are sensitive tools for the detection of early neonatal brain injury. 
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Methodological considerations 
Animal model
All the experimental protocols were approved by the Rikshospitalet University Hospital’s 
ethics committee for animal studies under the surveillance of the Norwegian Animal 
Research Authority, and performed by certified FELASA (Federation of European 
Laboratory Animal Science Associations) category C researchers. All efforts were made 
to:
x Reduce the number of included animals as much as possible while retaining the 
scientific requirements for statistical analysis. 
x Refine the models so as to minimise the group sizes while maximising the quality 
of acquired information. 
x Replace in vivo analysis by in vitro models when this would give equivalent 
information. This has not been possible in this thesis. 
x Relieve animals from any distress by careful handling and adequate analgesia and 
anaesthesia when needed. 
We have used 12-36 h old Noroc (LYxLD) pigs. These are a crossbreed between 
Norwegian Landrace (L) ½, Yorkshire (Y) ¼ and Duroc (D) ¼. They were transported to 
the laboratory by the farmer on the day of the experiment. Exclusion criteria were 
reduced general condition, wounds, dehydration, Hb < 5 g/dL, and weight less than 1200 
g. Anaemia in the newborn piglet is a familiar problem. Attempts to prevent the 
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development of anaemia in piglets by treating pregnant sows with iron show no effect 
(127). Total blood volume in a piglet is 70 ml/kg body weight and it is possible to 
withdraw 10% blood on the day of the experiment, excluding piglets less than 1200 g. 
To reduce the number of piglets we had to exclude, it was important to collaborate with 
the laboratory animal breeder. He had to be able to recognise the exclusion criteria and 
take them into account during breeding. The breeder’s routines for animal selection were 
improved.  
x Piglets with any of the above-mentioned visible exclusion criteria were not 
selected by the breeder. 
x The piglet was taken from the sow as late as possible on the day of the experiment 
to avoid dehydration and stress. Piglets become easily become stressed by rapid 
changes in environments such as being withdrawn from the sow. 
x The piglets were transported in a warm incubator to avoid hypothermia.  
It is difficult to study the pathophysiology of neonatal asphyxia in humans. Much of our 
current understanding concerning neonatal asphyxia derives from studies conducted in 
animal models (128, 129). An important prerequisite for the evaluation of an animal 
study is to know the possibilities and limitations of the experimental model. The best 
animal model of neonatal hypoxic ischemic cerebral, pulmonary and cardiac injury is 
presumably the one that most closely approximates the injury found in human infants. 
Over the last few decades, a large body of data has been gathered on newborn pigs. The 
size and body weight is makes this an attractive and workable model. The same type of 
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equipment usually used in the neonatal intensive care unit may be used during 
experiments. Their anatomy and physiology are in many areas close to that of humans 
(130).
However, both in human infants and in animal models, the localisation and extent of the 
injury observed will not only depend on the degree and duration of the insult, but also on 
the maturity of the brain, lungs and heart (131, 132). Animal models will always be an 
approximation to the clinical situation. Thus, the present work cannot be directly related 
to the resuscitation of asphyxic newborn infants.
It is important to take into considerations the differences between the species in terms of 
O2 responses, different biochemical responses, lack of reference values for common 
functional variables and different maturation at birth. We used a piglet model since its 
anatomy and physiology are quite similar to those of humans (130, 133). This model is 
time-consuming and it is expensive to obtain a large enough series for satisfactory 
statistical power. It must be emphasised that the animals in the present work were  
12-36 h old and were therefore to some extend adapted to extra-uterine life. Thus, 
whether our findings can be applied to the resuscitation of asphyxiated newborn infants 
should be determined through clinical trials.  
The piglet model is commonly used in medical research due to the similarities of the 
brain to the human brain (134). Studies have shown that the grey/white matter 
distribution, changes in brain morphology during development, and sequence of nervous 
system maturational changes, are comparable for pigs and humans (135). Also, the 
overall shape and gyral pattern of the piglet brain is similar to that of humans (136, 137). 
The histological maturation of the brain of a newborn piglet is considered to be 
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approximately the same as that of human infants of 36-38 weeks of gestation (138), but 
its physiology is probably more mature. Newborn piglets also have higher rates of 
cerebral metabolism and cerebral blood flow (CBF) than humans. Normal CBF has been 
found to be the highest in neonatal pigs and decreasing with age (139), which is in 
contrast to humans.  
Haworth et al studied the adaptation of pulmonary circulation to extra-uterine life in pigs 
and concluded that functionally the pulmonary circulation did not appear to be mature 
until the age of two weeks and that an adult pattern was established by the age of six 
months. The functional changes occurring in pulmonary circulation during the first two 
weeks of life follow a similar time course to those in the human infant (140).  
The cardiovascular system is rather similar to that of humans (133, 141). The ductus 
arteriosus is functionally closed within 4-20 h after birth.
My grandmother feeding the pigs in 1953. 
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Anaesthesia
The use of conscious animals in our studies would be unethical and of course not possible 
since the piglets easily become stressed during surgery. The use of anaesthetics is an 
absolute necessity, but represents a problem as the drugs may act as confounders. They 
may complicate the interpretation of results and make comparison with previous 
experiments difficult. However, the well-being of the animal must always be the first 
priority.
Anaesthesia was induced by Halothane 4% (Fluthane ® ZENECA). An ear vein was 
cannulated, halothane was disconnected, and the piglets were given Pentobarbital sodium 
20 mg/kg and Fentanyl 50Pg/kg iv as a bolus injection. In papers I-III anaesthesia was 
maintained by a continuous infusion of Fentanyl (50Pg/kg/h) and Midazolam 
(0.25mg/kg/h) (IVAC P2000 infusion pump).  In work IV, infusion pumps had to be 
avoided because of artefacts on the MRI images. The anaesthesia was therefore 
maintained during the experiment with a continuous inhalation of isoflurane (Abbot 
Scandinavia AB, Kista, Sweden) (1-1.5% MAC), and a mixture of N2O (30%) and O2
(70%) and an hourly bolus injection of Fentanyl 50 Pg/kg. A continuous iv infusion 
(Saline 0.7% and Glucose 1.25%, 20ml/kg/h) was given throughout each experiment. The 
depth of anaesthesia was monitored by response to painful stimuli elicited by pinching 
the nasal septum in addition to monitoring heart rate and blood pressure. If necessary, a 
bolus of Fentanyl (10Pg) or Midazolam (1mg) was added.  Before and during the 
experiment, we provided normal rectal temperature in the piglet between 38.5 ºC and 
39.5 ºC using a heating blanket and lamp.  
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Halothane decreases cerebrovascular resistance and increases cerebral blood flow (CBF) 
in a concentration-related manner provided auto regulatory limits are not exceeded. As a 
result, intracranial pressure (ICP) may increase. Cerebral auto regulation is lost when the 
concentration of Halothane increases (142). Halothane was only used for a few minutes 
to minimise influence on the results.  
In addition, the opioid Fentanyl was used as analgesia which in newborn piglets increases 
cerebral fractional oxygen extraction (143). Pigs require larger concentrations of 
morphine than dogs or other types of primates (144). Fentanyl dosages acceptable for 
humans may be inadequate for pigs (145). Studies have shown that, between the species, 
there are differences in the pharmacodynamic properties of opioid agonists (144, 146). 
One study concluded that Fentanyl infusions of 50-200 μg/kg/h reduced the minimum 
alveolar concentration of isoflurane in pigs (147). Fentanyl dosages used in research 
should therefore be evaluated carefully by the investigators to ensure minimal distress to 
the animal and to prevent the collection of misleading data (148). 
Pentobarbital sodium is an intermediate-acting barbiturate and is probably the most used 
anaesthetic drug in animal research. Barbiturates have been used as sole agents for 
anaesthesia in pigs. In the presence of pain, barbiturates can even induce hyperalgesia 
(149, 150). Unstable haemodynamic conditions will be produced by the large doses 
necessary to obtain sufficient analgesia (151-153). Pentobarbital sodium should be 
combined with an analgesic agent during painful procedures. Barbiturates have a dose-
dependent cardiovascular depressant effect which is well tolerated in pigs (142, 150). 
Barbiturates reduce CBF, intracranial pressure, cerebral metabolic rate of oxygen 
(CMRO2) (154, 155) and have anticonvulsant effects (149). Barbiturates also have a 
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neuroprotective effect on ischemia-induced brain damage (156, 157). Small bolus dose 
levels were used at the beginning of the anaesthesia and at the end to kill the piglet. The 
dose level used is not expected to influence the results.  
Midazolam is an effective sedative in pigs and has minimal effects on the cardiovascular 
system (158). Continuous infusion of Midazolam may, however, compromise the 
cerebral perfusion and oxygenation in piglets (159).
In paper IV the combination of isoflurane/N2O inhalation and bolus injections with 
Fentanyl iv were used. The inhalation agent isoflurane as a sole agent or in combination 
with nitrous oxide (N2O) has been demonstrated to provide the least cardio depressant 
effects while providing stable anaesthesia. Pigs are relatively resistant to the analgesic 
effects of N2O, which should therefore not be used as the sole analgesic agent during 
surgical procedures (133). The anaesthetics that were used could influence the 
metabolism and blood flow in brain, lungs and the heart, but this could not explain the 
differences between the groups.
Dose levels of anaesthetics for research animals have been developed through veterinary 
practice and from dose levels used in humans without considering variations between 
species (153, 160). Earlier, veterinary practice used lower doses if the animal was used 
for human consumption. Since required dose levels may differ considerably, care should 
be taken when applying anaesthetic protocols developed for humans to other species, 
such as pigs. 
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Microdialysis
In vivo microdialysis is a technique used to sample extracellular substances from intact 
tissue. Microdialysis was invented in the 1970s, and the microdialysis probe was 
originally developed as an attempt to mimic the passive function of a capillary blood 
vessel by perfusing a thin dialysis tube implanted into the tissue. The technique can be 
performed in almost any organ and tissue (161). Initially used in animal studies, the 
technique is now being used on humans, especially in neurosurgical patients (162-165). 
The microdialysis probe is continuously flushed by artificial extracellular fluid, and 
consists of a thin membrane perforated with holes of a specific diameter (“cut-off value” 
for molecules that can, or cannot pass through). Inside the probe, a thin needle extracts 
the dialysate, which can be analysed as illustrated below.
Usually, microdialysis measures only a fraction of the actual concentration of the 
substance in question. As the probe is constantly perfused, the dialysate is removed and a 
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concentration gradient is created from the extracellular fluid to the dialysate. The 
concentration of the collected substance is therefore always lower in the dialysate than in 
the extracellular fluid. The dialysate/extracellular concentration ratio expressed as a 
percentage is called the microdialysis extraction fraction or in vivo recovery. The 
diameter of the holes in the dialysis membrane is in general so small that it excludes 
larger molecules, such as enzymes, that would break down smaller molecules that are 
essential to metabolism or signalling. Thus, the dialysate from the probe is thought to 
accurately reflect the extracellular levels of these small molecules. However, as dialysis 
is based on passive diffusion, the flow rate at which the artificial extracellular fluid 
passes the membrane is crucial in determining the ratio between the true extracellular 
levels and the levels in microdialysate samples. The absolute recovery (mol/time unit) of 
substance from the tissue depends on the “cut off” of the dialysis membrane (usually 
defined as the molecular weight in Daltons, at which 80% of the molecules are prevented 
from passing through the membrane), the length of the membrane, the flow of the 
perfusion fluid and the diffusion coefficient of the compound through the extracellular 
fluid. A flow rate of 1μL/minute was used in these studies. Tissue temperature, blood 
flow and the metabolism of the collected substance may also influence an in vivo 
recovery. The introduction of a probe into the tissue will always cause damage and the 
recovery of function will take a certain period of time. An hour is often used to reach 
baseline conditions. Microdialysis probes were mounted on the stereotactic frame and 
inserted into corpus striatum as seen below. The analysis of microdialysate has been 
performed in a CMA 600 Microdialysis Analyzer. The illustration is reprinted with 
permission from CMA/Microdialysis AB.  
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Microdialysis as described above. 
Biological markers and imaging techniques 
Matrix metalloproteinases
The expression of MMPs can be analysed by several techniques. Total MMP activity is 
an analysis of the joint capacity of MMP-1, MMP-2, MMP-7, MMP-8, MMP-9, MMP-12 
and MMP-13 using a fluorogenic peptide substrate (cat no: ES001, R&D systems). The 
total activity of these enzymes is expressed by Relative Fluorogenic Unit (R.F.U.). A 
widely used technique is substrate zymography, which identifies MMPs by the 
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degradation of their preferential substrate and by their molecular weight. Using this 
technique, it can be determined whether the MMP is in active or latent form. To localise 
MMPs in tissue sections in situ zymography can be performed.  
Gelatin zymography 
Gelatin zymography is based on the following principles: 1) during electrophoresis, 
gelatine is retained in the gel, 2) MMP activity is reversible inhibited by SDS during 
electrophoresis, and 3) the SDS causes the separation of MMP-TIMP (tissue inhibitors of 
metalloproteinases) complexes during electrophoresis. Another advantage of gelatine 
zymography is that both the proenzyme and the active forms of MMPs can be 
distinguished on the basis of their molecular weight (166). Because gelatine zymography 
only indicates whether the proenzyme displays in the presence of TIMP in vivo, it is 
uncertain how much activity the active form would display in the presence of TIMP in
vivo (166). Furthermore, the digestion of gelatin by pro-MMPs is somewhat reduced 
because the latent form still retains its propeptide domain. 
Gelatin zymography is mainly used for the detection of the gelatinases MMP-2 and 
MMP-9. It is extremely sensitive so that levels of 10 pg of MMP-2 can be detected (167). 
It is an adaptation of substrate zymography that is suitable for frozen sections. The nature 
of the substrate dictates which MMP can be detected (168). In addition, the extraction 
procedures can artifactually activate enzymes or result in the interaction of active 
enzymes with their respective inhibitors, which may have been localised in distinct 
compartments in the intact cells or tissue. Likewise, if a specific protease activity is 
localised in a relatively small part of a diseased tissue, it may not be detected because of 
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its dilution in the entire tissue extract. For these reasons, techniques to localize specific 
proteolytic activity in tissue sections may provide crucial additional information on the 
exact role played by certain proteases in various physiologic and pathologic conditions. 
To identify the gelatinases in our gels we used a human and molecular weight standard. 
At that time there was no pig standard available to identify the zymography-bands, which 
would have made our identification more precise. 
In situ zymography
In situ zymography (ISZ) is a relatively low-cost technique that uses a substrate which 
deposited on or under a frozen section of an unfixed tissue sample. During incubation, the 
substrate will be digested by the activated MMPs in a time- and dose-dependent manner 
and offers the ability to estimate different protease activities in combination with the 
localisation of these activities in tissue sections (169). Only active MMPs are detected. 
The degradation of the substrate is detected by light microscopy or fluorescence 
microscopy, depending on the type of substrate (170). A limitation of this technique is the 
difficulty to discriminate between the different classes of MMPs. The MMPs are detected 
using a photographic emulsion or a fluorescent substrate. ISZ is a useful tool which can 
be used to localise protease activity in tissue sections in an inexpensive and rapid manner. 
A disadvantage of the photographic method is the difficulty to standardise the method 
(171).
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In situ zymography showing net gelatinolytic activity in pulmonary tissue. 
1) Epithelium 
2) Cartilage 
3) Bronchial lumen 
4) Submucosa 
5) Alveoli 
Baseline                                              Resuscitation with 100% oxygen 
Analysis of gene expression
Total RNA was isolated using silica-gel based membranes (RNeasy columns). All RNA 
samples were treated with DNase to eliminate the contamination of small amounts of 
DNA. The concentration and purity was evaluated by measuring the absorbency at 
260/280 nm and the integrity of total RNA by the use of agarose gel electrophoresis. 
Only samples with high integrity and purity were used in the experiments.  
To identify and quantify gene expression of specific transcripts we used real-time reverse 
transcriptase polymerase chain reaction (real-time RT-PCR). This is a sensitive method 
for the detection of low-abundance mRNA. In contrast to conventional RT-PCR, the 
accumulation of the PCR-product is monitored for each cycle using a fluorogenic 
sequence specific probe (e.g. TaqMan probes). This makes it possible to collect the data 
in the exponential phase of the amplification, obtaining reliable quantitative results 
dependent on optimising internal standards.  
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To correct for sample-to-sample variation, normalisation of gene expression was 
performed against 18S ribosomal RNA. The genes used for normalisation should ideally 
not be subject to any regulation in the tissue or cells investigated (159).
When the gene expression analysis was performed, there were only a few gene sequences 
available for pigs. Far more gene sequences are currently available and it is now possible 
to purchase gene expression microarray that contain more than 20 000 pig genes. 
Oxygen radical absorption capacity 
The oxygen radical absorption capacity (ORAC) assay is a method for measuring the 
total antioxidant potential of a biological sample.  The ORAC assay measures the time-
dependent decrease in the fluorescence intensity of the ȕ - PE (beta-phycoerythrin) 
marker protein resulting from its oxygen binding, and represents oxygen radical damage. 
On a molar basis, the ȕ - PE protein reacts with oxygen radicals over 100 times slower 
than most biological antioxidants such as thiols, uric acid, bilirubin and ascorbate. 
However, ȕ - PE is over 60 times more reactive than other non-antioxidant proteins. The 
analyser is programmed to record the fluorescence of ȕ - PE every two minutes after the 
addition of AAPH (2, 2’-azobis (2-amidinopropane)dihydrochloride).  Each reaction is 
calibrated using known standards of Trolox®, a water soluble vitamin E analogue. The 
results of the assay are reported on the basis of 1 ORAC unit = 1 μM Trolox® (172). The 
principal drawback of this assay is ȕ - PE itself since it varies from lot to lot and is not 
very photostable (173). Considering these disadvantages an improved ORAC assay 
employing fluorescein (FL) as the fluorescent probe (ORAC-FL) was developed. FL as 
compared to ȕ - PE does not interact with antioxidants, shows an excellent photostability, 
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and reduces the cost of experiments (174, 175). Unfortunately, this method was not yet 
established in the laboratory during this study but will be used in further projects. 
Magnetic resonance imaging 
Perfusion and diffusion magnetic resonance imaging (MRI) are two relatively new 
methods whereby tissue perfusion and cellular water mobility can be directly assessed 
(124). In perfusion MRI, the temporal effect of an iv injected contrast agent on the MR 
signal is measured. The observed effect can then be used to assess relative tissue 
perfusion by applying a kinetic model of the known distribution of the contrast agent in 
tissue. PWI has proved to be a sensitive method for detecting ischemia since the dynamic 
contrast agent effect directly reflects local tissue perfusion. In diffusion MRI, 
microscopic water diffusion can be measured by applying additional magnetic fields 
which vary as a function of time and positions. The resulting DWI image reflects the 
apparent diffusion coefficient (ADC) of water at the cellular level, which has proved to 
be an extremely sensitive marker for early cellular damage following HI. Both DWI and 
PWI suffer from limited spatial resolution compared with standard structural MRI. 
Therefore, both these techniques could only be used to assess functional changes 
affecting a large proportion of the cerebral volume in the present work. In further studies, 
a dedicated animal scanner with a smaller magnet bore and a higher field strength should 
be considered since this would improve the spatial resolution and signal-to-noise and 
thereby the sensitivity when detecting functional changes on a smaller scale. A suitable 
animal scanner was not available at Rikshospitalet when these studies were performed.  
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Summary of results 
Paper I 
Resuscitation with 100% O2 Increases Cerebral Injury in 
Hypoxemic Piglets 
Extracellular cerebral glycerol values were 50% higher in the piglets resuscitated with 
100% oxygen compared to 21% oxygen at 90, 120 and 150 min after resuscitation (p < 
0.05, independent sample t test at each time point). Total MMP activity was two-fold 
higher in resuscitated animals compared with controls (p = 0.018). MMP-2 activity was 
significantly higher in the animals resuscitated with 100% oxygen compared with 21% 
oxygen. mRNA expression of MMP-2 was significantly higher in piglets resuscitated 
with 100% oxygen compared with 21% oxygen (p < 0.05). Total antioxidant capacity, 
ORAC, was considerably lowered in the piglets resuscitated with 100% oxygen 
compared to 21% oxygen (p = 0.001). These results suggested a less favourable cerebral 
outcome in the group reoxygenated with 100% compared with 21% oxygen. 
Mean arterial blood pressure, base excess and pH were all similar between the two 
resuscitation groups at baseline, at the end of the insult and at the end of the experiment. 
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Paper II 
Resuscitation of hypoxic piglets with 100% oxygen increases 
pulmonary metalloproteinases and IL-8 
In pulmonary tissue, pro- and active- MMP-2 levels were increased in piglets resuscitated 
with 100% O2 compared to 21% O2 (p < 0.05). Pro-MMP-9, total MMP activity and 
MMP-2 mRNA levels were significantly increased in resuscitated piglets compared to 
baseline (p < 0.05). Net gelatinolytic activity increased in submucosa and blood vessels 
after 100% O2 (p < 0.05), and only in the blood vessels after 21% O2. Compared to 
baseline, ORAC values were considerably lowered in the resuscitated piglets (p < 0.05) 
and significantly reduced in the 100% O2 versus 21% O2 group (p < 0.05). In BAL fluid, 
both pro-MMP-9 and pro-MMP-2 increased two-fold in the 100% O2 group compared to 
21% O2 (p < 0.05). Moreover, IL-8 concentration increased significantly in piglets 
resuscitated with 100% O2 compared to 21% O2 (p < 0.05) suggesting a marked pro 
inflammatory response in the pulmonary tissue. Altogether, these data strongly suggest 
that caution must be taken when applying pure oxygen to the newborn infants. 
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Paper III 
Increased myocardial matrix metalloproteinases in hypoxic 
newborn pigs during resuscitation: effects of oxygen and carbon 
dioxide 
MMP-2 more than doubled from baseline values (p < 0.001), and was higher in piglets 
resuscitated with 100% O2 than with ambient air (p = 0.012). The ORAC value was 
considerably decreased in piglets resuscitated with 100% O2 compared with baseline (p < 
0.001). In piglets with elevated PaCO2, total MMP activity in the right ventricle was 
more increased than in the left ventricle (p = 0.008). In the left ventricle total MMP-
activity was higher in piglets with low PaCO2 than in piglets with elevated PaCO2 (p = 
0.013). In hypoxaemia-reoxygenation injury the MMP-2 level was highly increased and 
was most elevated in the piglets resuscitated with 100% O2. Antioxidant capacity was 
considerably decreased. Assessed by total the MMP-activity, elevated PaCO2 during
resuscitation might protect the left ventricle, and probably increase the right ventricle 
injury of the myocardium. 
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Paper IV 
Morphological and haemodynamic MR assessment of early 
neonatal brain injury in a piglet model 
A linear correlation was observed between the relative cerebral perfusion reduction and 
the cerebral apparent diffusion coefficient (ADC) during HI (r2 = 0.85, p < 0.05). There 
was no correlation between the rCBF reduction during 30 minutes of HI and the cerebral 
ADC after 30 or 150 minutes of reperfusion/reoxygenation (RR). The MR angiography 
enabled consistent assessment of the presence, absence and also recovery of complete 
occlusion of the extracranial carotid arteries. Ligation of the extracranial arteries in the 
piglet produced an unpredictable degree of ischemia due to considerable interindividual 
variations of vessel communication between the two hemispheres, between extra- and 
intracerebral arteries, and between vertebral and carotid arteries. A single bolus of 
intravascular contrast agent allowed measurement of perfusion and depiction of vessel 
anatomy, providing a comprehensive tool for both a morphological and haemodynamic 
assessment of ischemia and hypoxia.  
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Discussion
Our findings demonstrate that resuscitation of hypoxic piglets with 100% O2 causes more 
upregulation of early markers of tissue injury than resuscitation with 21% O2. This was 
detected in cerebral, pulmonary as well as myocardial tissue based on extracellular 
markers of tissue damage and matrix metalloproteinases. The time span of these 
experiments is relatively short. After hypoxia and resuscitation, the piglets were observed 
for only two and a half hours. We are therefore not able to conclude whether the observed 
changes are relevant for the long-term outcome. However, the acute tissue damage 
markers glycerol (in brain) and IL-8 (in lung) were considerably increased – allowing us 
to believe that the tissue damage in the piglets is significant and would probably have 
affected their clinical outcome. It is interesting that the MMPs were significantly 
increased in the brain, heart, and lungs when resuscitated with pure oxygen.
There is an ongoing debate on whether to use ambient air or 100% O2 in neonatal 
resuscitation (44, 176-178). Clinical studies have even indicated that hyperoxic treatment 
of the newborn may have detrimental effects in childhood. For term and near-term 
infants, Davis et al conclude that air should be used initially, with oxygen as backup if 
initial resuscitation fails (53). A Cochrane review concludes that there is insufficient 
evidence at present on whether to recommend room air or 100% oxygen for newborn 
resuscitation. If ambient air is chosen as the initial gas for resuscitation, supplementary 
oxygen should be available (179).
Our findings, showing the detrimental effects of hyperoxic resuscitation in the piglet, add 
information to this debate. Further studies must be done to investigate mechanisms that 
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explain our findings. Gene activation, repair and down-regulation in different tissue, 
following global hypoxia and hyperoxic resuscitation should be analysed. It seems that 
pure oxygen in contrast to room air for resuscitation changes a number of genes and that 
a similar effect is found in multiple organs in the piglet. Secondary energy failure has 
been described in the brain after hypoxia- ischemia (21). The effect of hyperoxia on 
mitochondrial function should be investigated by determining the levels of electron 
transport chain proteins encoded by mitochondrial and nuclear DNA, assessing the effect 
of hyperoxia on oxidative phosphorylation and the transcription of nuclear and 
mitochondrial genes.  
HIE remains a major marker of perinatal and neonatal morbidity, as well as of permanent 
neurodevelopmental disability. Early detection is crucial for interventions aimed at 
preventing or reversing ongoing injury. Currently, treatment of HIE lacks accurate 
predictors for the long-term outcome (6). We conclude that MRI is capable of detecting 
early cerebral changes after hypoxia-ischemia with diffusion and perfusion MRI. This is 
a promising and powerful tool regarding the utility of MRI to monitor early cerebral 
damage, although we do not know at the moment the ideal time span for MRI 
investigations in the newborn. In addition, proton magnetic resonance spectroscopy 
(HMRS) will enable us to measure the various metabolite ratios in vivo in normal and 
pathologic conditions (6). The combination of MRI and HMRS may make it possible to 
evaluate severity and may help predict the prognosis of HIE.
This thesis has investigated the acute changes after hypoxia-reperfusion. Further animal 
and clinical studies must be done to assess the long-term effects.  
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Like every other drug, oxygen also has side-effects. However, oxygen will always be an 
important drug in medicine. Oxygen supply should be optimised regarding dosage, 
concentration and time. If oxygen is given, it should be tapered as quickly as possible. 
Optimally, oxygen saturation should be followed continuously by a pulse oxymeter. The 
recommended dosage of oxygen during newborn resuscitation will most likely be 
reduced.
Conclusions
I Cerebral, pulmonary and myocardial tissue damage was more extensive assessed 
by MMPs in the group resuscitated with 100% O2 compared with 21% O2 suggesting a 
less favourable outcome with pure oxygen (Paper I, II, and III). 
II Cerebral extracellular glycerol and pulmonary IL-8 was more extensive in the 
group resuscitated with 100% O2 compared with 21% O2. This suggests a less favourable 
cerebral and pulmonary outcome in the hyperoxic group (Paper I and II). 
III There were no significant differences in any cerebral or pulmonary outcome 
measures between different PaCO2 levels (Paper I and II).
IV Elevated PaCO2 during resuscitation might protect the left ventricle, and probably 
increase right ventricle damage of the myocardium. The resuscitation procedure is 
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important to the myocardium since the PaCO2 level also has to be addressed to avoid 
additional iatrogenic tissue injury during the resuscitation of neonatal piglets (Paper III). 
V Diffusion and perfusion MR imaging enabled consistent detection of early 
cerebral changes, and MR angiography provided visualization of the presence, absence, 
and recovery of complete carotid occlusion (Paper IV). 
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Errata
Paper III 
Results, p 462, second column, Total MMP activity, fourth line should read; “Left 
ventricle total MMP-activity increased in group A1/B1 (14930·0 R.F.U. ± 922, 
P = 0·003) and group A2/B2 (13634·5 R.F.U. ± 1240, P = 0·027) compared to the control 
piglets (9606·5 R.F.U. ± 1453)”. 
78
